S&P Futures
3,776.75 -12.75 (-0.34%) Dow Futures
30,673.00 -108.00 (-0.35%) Nasdaq Futures
11,489.00 -40.50 (-0.35%) Russell 2000 Futures
1,700.20 -7.80 (-0.46%) Crude Oil
107.36 +1.60 (+1.51%) Gold
1,792.30 -15.00 (-0.83%)
SomaLogic, Inc. (SLGC)
After hours:
Chart Events
Performance Outlook
| Previous Close | 4.6800 |
| Open | 4.6000 |
| Bid | 0.0000 x 4000 |
| Ask | 0.0000 x 2900 |
| Day's Range | 4.4000 - 4.6500 |
| 52 Week Range | 4.2000 - 14.7200 |
| Volume | |
| Avg. Volume | 1,779,852 |
| Market Cap | 818.902M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy trea
- GlobeNewswire
SomaLogic Announces June Conference Participation
BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare ConferenceJune 8-9, 2022, in New York 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics ConferenceJoe Gogain, Director, Clinical R&D will present “Bigger data = better data. Detect 7,000 proteins at once with high throughput to optimize biomarker discover” durin
- GlobeNewswire
SomaLogic Reports First Quarter 2022 Financial Results
Company to host conference call today at 4:30 p.m. ETBOULDER, Colo., May 12, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended March 31, 2022. “Our successful first quarter has kickstarted another exciting year for SomaLogic as we continue to apply the power of the human proteome to improve health and disease management,” said Roy Smythe, M.D., SomaLogic’s Chief Executive Officer. “We have already re
